Please login to the form below

Not currently logged in
Email:
Password:

HAS

This page shows the latest HAS news and features for those working in and with pharma, biotech and healthcare.

Pfizer/BioNTech reach vaccine supply agreement with COVAX

Pfizer/BioNTech reach vaccine supply agreement with COVAX

COVAX is aiming to secure two billion vaccines in 2021 – the global initiative now has agreements in place to access just over this amount, according to the WHO. ... COVAX also has a statement of intent from Sanofi and GlaxoSmithKline (GSK) for 200

Latest news

  • AstraZeneca reduces initial COVID-19 vaccine deliveries to the EU AstraZeneca reduces initial COVID-19 vaccine deliveries to the EU

    Deliveries in the first quarter have been cut by 60%. AstraZeneca (AZ) has notified the EU that it will reduce initial deliveries of its Oxford-partnered COVID-19 vaccine by 60% ... vaccine. The news that AZ has reduced the planned deliveries for its

  • BMS gains FDA approval for second Opdivo combo in kidney cancer BMS gains FDA approval for second Opdivo combo in kidney cancer

    The US Food and Drug Administration (FDA) has approved a combination of Bristol Myers Squibb’s (BMS) Opdivo with Exelixis’ Cabometyx in renal cell carcinoma (RCC) – the most common type of ... The European Medicines Agency (EMA) has already

  • Merck ends its COVID-19 vaccine programme after disappointing early trial results Merck ends its COVID-19 vaccine programme after disappointing early trial results

    Merck &Co (MSD) has ended its COVID-19 vaccine programme after reviewing some disappointing phase 1 results for its candidates V590 and V591.

  • In plain sight In plain sight

    In previous years the award has gone to ‘science’. In 1960, the award went to the collective referred to as ‘US Scientists’ and. ... To the Bill and Melinda Gates foundation and every other single foundation across the globe that has tried to

  • Janet Woodcock named acting commissioner of the FDA Janet Woodcock named acting commissioner of the FDA

    Woodcock has served as the director of the Centre for Drug Evaluation and Research since 2007, and also worked in the same role between 1994 and 2005. ... Most recently, she has worked as part of the US government’s Operation Warp Speed, as part of the

More from news
Approximately 1 fully matching, plus 7,398 partially matching documents found.

Latest Intelligence

  • An EU emergency health fund to limit the impact of future crises An EU emergency health fund to limit the impact of future crises

    However, just over a decade later, the world has found itself in yet another systemic crisis – The Great Lockdown Crisis of 2020. ... Securities that result from risk securitisation are known as Insurance Linked Securities, or ILS, the market of which

  • The pandemic preparedness paradox The pandemic preparedness paradox

    Then during a pandemic, there are buyers but no sellers, at least until the sellers can catch up, react and develop products, after which time the devastation has already occurred. ... and the seller has captured a large and negative return (recall, the

  • Sourcing R&D innovation: why pharma companies need to evolve their business models Sourcing R&D innovation: why pharma companies need to evolve their business models

    This approach has proven successful for many companies, but recent years have seen a significant shift in drug development to specialty areas including rare diseases. ... Now that there are multiple approved therapies available for these general

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    The European Commission has signed a joint procurement agreement for Gilead’s COVID-19 antiviral treatment remdesivir. ... Since January, Gilead has taken multiple steps to ramp up production and rapidly build supply in recognition of the lengthy

  • 2021: the year of decentralisation in drug development 2021: the year of decentralisation in drug development

    Historically, access to clinical trials, and subsequently low enrolment, has been one of the greatest hindrances to clinical trial efficiency. ... Identifying the development of symptoms has the potential to not only mitigate symptoms, but also improve

More from intelligence
Approximately 0 fully matching, plus 1,124 partially matching documents found.

Latest appointments

  • 3 Monkeys Zeno taps Avril Lee to lead UK and EU healthcare business 3 Monkeys Zeno taps Avril Lee to lead UK and EU healthcare business

    Lee joins from The Red Consultancy. 3 Monkeys Zeno (3MZ) has appointed Avril Lee to the role of head of healthcare, UK and EU. ... She has also held senior healthcare roles at agencies including MSL and Ketchum, and has worked with clients including Bayer

  • David Eatwell joins Porterhouse Insights David Eatwell joins Porterhouse Insights

    Eatwell joins the Porterhouse team from Cello Health Insight. Porterhouse Medical Group has appointed David Eatwell director in its research, insight and evidence consultancy Porterhouse Insights. ... Eatwell has a background in both qualitative and

  • Research Partnership appoints Hannah Osborn to MedTech director role Research Partnership appoints Hannah Osborn to MedTech director role

    Osborne has previously worked at Ipsos and IQVIA. Research Partnership has appointed Hannah Osborn as a MedTech director in its London, UK office. ... Osborn (pictured left) has over 13 years’ experience in healthcare research and consulting, with a

  • New hire and promotions announced at Evoke KYNE New hire and promotions announced at Evoke KYNE

    Cooper Welty (pictured left) has worked at Evoke KYNE since 2013 – prior to this, she worked as a consultant. ... Rounding out the appointments at Evoke KYNE is Karen Urban (pictured left), who has also joined as a vice president.

  • New executive appointments at Synergy Vision New executive appointments at Synergy Vision

    Gallagher has worked at Synergy Vision since its inception, having been part of the founding team. ... She has over 20 years of healthcare communication experience, across both the client and agency settings.

More from appointments
Approximately 0 fully matching, plus 1,007 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1,022 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics